A new clinical trial funded by the Natasha Allergy Research Foundation is showing promising results in treating children with peanut and milk allergies using oral immunotherapy. The trial has already helped 139 patients aged two to 23 improve their tolerance to allergens, with plans to expand to more hospitals in the UK. The ultimate goal is to provide a life without the risk of severe allergic reactions.
Key Points
Funded by the Natasha Allergy Research Foundation
139 patients aged 2-23 have started treatment
Five NHS hospitals are participating in the trial
Goal to provide life without the risk of severe allergic reactions
Pros
Promising results in improving tolerance to peanuts and cow's milk for allergy patients
Life-transforming treatment for patients with severe food allergies
Potential for more everyday foods treatment options to be available on the NHS
Cons
Treatment is not a cure for food allergies
Requires ongoing medical supervision and monitoring